306 related articles for article (PubMed ID: 10987817)
1. Identification and characterization of nuclear factor kappaB binding sites in the murine bcl-x promoter.
Glasgow JN; Wood T; Perez-Polo JR
J Neurochem; 2000 Oct; 75(4):1377-89. PubMed ID: 10987817
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain.
Glasgow JN; Qiu J; Rassin D; Grafe M; Wood T; Perez-Pol JR
Neurochem Res; 2001 Jun; 26(6):647-59. PubMed ID: 11519724
[TBL] [Abstract][Full Text] [Related]
3. Involvement of 5'-flanking kappaB-like sites within bcl-x gene in silica-induced Bcl-x expression.
Chen F; Demers LM; Vallyathan V; Lu Y; Castranova V; Shi X
J Biol Chem; 1999 Dec; 274(50):35591-5. PubMed ID: 10585435
[TBL] [Abstract][Full Text] [Related]
4. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.
Jiang HY; Petrovas C; Sonenshein GE
J Virol; 2002 Jun; 76(11):5737-47. PubMed ID: 11992002
[TBL] [Abstract][Full Text] [Related]
5. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
[TBL] [Abstract][Full Text] [Related]
6. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.
Grimm T; Schneider S; Naschberger E; Huber J; Guenzi E; Kieser A; Reitmeir P; Schulz TF; Morris CA; Stürzl M
Blood; 2005 Apr; 105(8):3263-9. PubMed ID: 15613549
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of NF-kappaB proteins by cyclic GMP-dependent kinase. A noncanonical pathway to NF-kappaB activation.
He B; Weber GF
Eur J Biochem; 2003 May; 270(10):2174-85. PubMed ID: 12752437
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor kappaB/p49 is a negative regulatory factor in nerve growth factor-induced choline acetyltransferase promoter activity in PC12 cells.
Toliver-Kinsky T; Wood T; Perez-Polo JR
J Neurochem; 2000 Dec; 75(6):2241-51. PubMed ID: 11080175
[TBL] [Abstract][Full Text] [Related]
9. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of CCL22 gene expression in murine dendritic cells and B cells.
Ghadially H; Ross XL; Kerst C; Dong J; Reske-Kunz AB; Ross R
J Immunol; 2005 May; 174(9):5620-9. PubMed ID: 15843561
[TBL] [Abstract][Full Text] [Related]
11. Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB.
Dehbi M; Hiscott J; Pelletier J
Oncogene; 1998 Apr; 16(16):2033-9. PubMed ID: 9572484
[TBL] [Abstract][Full Text] [Related]
12. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
[TBL] [Abstract][Full Text] [Related]
13. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
Yu Z; Zhang W; Kone BC
Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
[TBL] [Abstract][Full Text] [Related]
14. High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer.
Perrella MA; Pellacani A; Wiesel P; Chin MT; Foster LC; Ibanez M; Hsieh CM; Reeves R; Yet SF; Lee ME
J Biol Chem; 1999 Mar; 274(13):9045-52. PubMed ID: 10085153
[TBL] [Abstract][Full Text] [Related]
15. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment.
Chan H; Bartos DP; Owen-Schaub LB
Mol Cell Biol; 1999 Mar; 19(3):2098-108. PubMed ID: 10022897
[TBL] [Abstract][Full Text] [Related]
16. Differential NF-kappa B regulation of bcl-x gene expression in hippocampus and basal forebrain in response to hypoxia.
Qiu J; Grafe MR; Schmura SM; Glasgow JN; Kent TA; Rassin DK; Perez-Polo JR
J Neurosci Res; 2001 May; 64(3):223-34. PubMed ID: 11319766
[TBL] [Abstract][Full Text] [Related]
17. Suppression of transcription factor NF-kappaB activity by Bcl-2 protein in NIH3T3 cells: implication of a novel NF-kappaB p50-Bcl-2 complex for the anti-apoptotic function of Bcl-2.
Hour TC; Chen L; Lin JK
Eur J Cell Biol; 2000 Feb; 79(2):121-9. PubMed ID: 10727020
[TBL] [Abstract][Full Text] [Related]
18. NF- kappa B2/p100 induces Bcl-2 expression.
Viatour P; Bentires-Alj M; Chariot A; Deregowski V; de Leval L; Merville MP; Bours V
Leukemia; 2003 Jul; 17(7):1349-56. PubMed ID: 12835724
[TBL] [Abstract][Full Text] [Related]
19. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.
Hatada EN; Do RK; Orlofsky A; Liou HC; Prystowsky M; MacLennan IC; Caamano J; Chen-Kiang S
J Immunol; 2003 Jul; 171(2):761-8. PubMed ID: 12847243
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
